Finance

Lists
EQ:NASDAQ
Equillium Inc
1,62 US$
+0,31%
(+0,0050) 1D
1,62 US$
-0,31% (-0,0051)
After hours
Closed: 30 სექ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EQ...
Open
1,63 US$
High
1,66 US$
Low
1,58 US$
Mkt. cap
103,04 მლნ.
Avg. vol.
506,76 ათ.
Volume
3,10 მლნ.
52-wk high
3,54 US$
52-wk low
0,76 US$
EPS
-0,20 US$
Beta
1,81
Shares outstanding
63,41 მლნ.
No. of employees
15
Open
1,63 US$
High
1,66 US$
Low
1,58 US$
Mkt. cap
103,04 მლნ.
Avg. vol.
506,76 ათ.
Volume
3,10 მლნ.
52-wk high
3,54 US$
52-wk low
0,76 US$
EPS
-0,20 US$
Beta
1,81
Shares outstanding
63,41 მლნ.
No. of employees
15
News stories
From web sources and news partners
About Equillium Inc
CEO-
Employees15
Founded2017
Headquarters-
Sector-
Websiteequilliumbio.com
Analyst ratings
Based on 5 analysts giving stock ratings to EQ in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for EQ in the last 3 months.
Highest
Current 1,62 US$
20,00 US$ (+1 130,77%)
Average
11,60 US$ (+613,85%)
Lowest
7,00 US$ (+330,77%)
Analyst
Recommendation
Action
Price target
Projected
Date
Adam Walsh
Roth MKM
Buy
Reiterated
12,00 US$
+638,5%
09/04/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
10,00 US$
+515,4%
08/14/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
7,00 US$
+330,8%
08/14/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
9,00 US$
+453,8%
08/03/2026
Yasmeen Rahimi
Piper Sandler
Buy
Initiated
20,00 US$
+1 130,8%
07/13/2026
William Wood
B. Riley Securities
Buy
Reiterated
6,00 US$
+269,2%
06/02/2026
Martin Auster
Raymond James
Buy
Maintained
7,00 US$
+330,8%
05/28/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Reiterated
5,00 US$
+207,7%
05/28/2026
Thomas Smith
Leerink Partners
Buy
Upgraded
6,00 US$
+269,2%
05/28/2026
David Siffringer
Cantor Fitzgerald
Buy
Initiated
10,00 US$
+515,4%
04/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,30 მლნ.
1,54 მლნ.
2,99 მლნ.
2,75 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,27 მლნ.
2,43 მლნ.
2,62 მლნ.
2,41 მლნ.
Operating expense
4,58 მლნ.
3,96 მლნ.
5,61 მლნ.
5,16 მლნ.
Total operating expenses
4,58 მლნ.
3,96 მლნ.
5,61 მლნ.
5,16 მლნ.
Operating income
-4,58 მლნ.
-3,96 მლნ.
-5,61 მლნ.
-5,16 მლნ.
Other non operating income
-
-
-
-
EBT including unusual items
-4,23 მლნ.
-3,78 მლნ.
-5,31 მლნ.
-4,69 მლნ.
EBT excluding unusual items
-4,23 მლნ.
-3,78 მლნ.
-5,31 მლნ.
-4,69 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4,23 მლნ.
-3,78 მლნ.
-5,31 მლნ.
-4,69 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-0,06
-0,04
-0,06
-0,04
Interest and investment income
235,00 ათ.
303,00 ათ.
309,00 ათ.
509,00 ათ.
Interest expense
-
-
-
-
Net interest expenses
235,00 ათ.
303,00 ათ.
309,00 ათ.
509,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-4,55 მლნ.
-3,94 მლნ.
-5,59 მლნ.
-5,13 მლნ.
Gain or loss from assets sale
-
19,00 ათ.
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები